Does GUSELKUMAB Cause Product dose omission issue? 9,267 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9,267 reports of Product dose omission issue have been filed in association with GUSELKUMAB (TREMFYA). This represents 33.1% of all adverse event reports for GUSELKUMAB.
9,267
Reports of Product dose omission issue with GUSELKUMAB
33.1%
of all GUSELKUMAB reports
2
Deaths
78
Hospitalizations
How Dangerous Is Product dose omission issue From GUSELKUMAB?
Of the 9,267 reports, 2 (0.0%) resulted in death, 78 (0.8%) required hospitalization, and 1 (0.0%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GUSELKUMAB. However, 9,267 reports have been filed with the FAERS database.
What Other Side Effects Does GUSELKUMAB Cause?
Accidental exposure to product (2,941)
Drug ineffective (1,971)
Needle issue (1,933)
Psoriasis (1,817)
Device issue (1,613)
Device malfunction (1,410)
Off label use (1,186)
Product storage error (1,017)
Inappropriate schedule of product administration (830)
Device deployment issue (778)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
GOLIMUMAB (4,216)
Which GUSELKUMAB Alternatives Have Lower Product dose omission issue Risk?
GUSELKUMAB vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX
GUSELKUMAB vs HALDOL
GUSELKUMAB vs HALOBETASOL
GUSELKUMAB vs HALOPERIDOL
GUSELKUMAB vs HALOPERIDOL DECANOATE